Dermatovenerologická klinika, Fakultní nemocnice Bulovka
- Address
- Budínova 67/2, Praha 8 – Libeň 180 81, 180 81 Prague, Czechia
Dermatovenerologická klinika, Fakultní nemocnice Bulovka
The Dermatovenerologická klinika at Fakultní nemocnice Bulovka is a specialized dermatology research center with expertise in autoimmune bullous diseases. The clinic focuses on advancing treatment options for complex dermatological conditions through participation in international clinical trials investigating novel therapeutic approaches.
- Long-term safety and efficacy studies of biologics in autoimmune skin disorders
- Bullous pemphigoid and blistering skin disease research
- Subcutaneous immunotherapy delivery systems
The center is actively involved in evaluating innovative treatments such as efgartigimod PH20 SC, a subcutaneous therapy targeting bullous pemphigoid. Through open-label extension studies, the clinic contributes valuable data on long-term safety, tolerability, and efficacy outcomes in adult patients with rare autoimmune dermatological conditions, helping to expand therapeutic options for patients with challenging skin diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dermatovenerologická klinika, Fakultní nemocnice Bulovka
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adults with Bullous Pemphigoid: An Open-label Extension Study | Argenx | Phase III | Not Recruiting | May 2022 | Jan 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Efgartigimod Alfa | 1 | Unknown | 2022-05-03 | 2022-05-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.